Richard William Scalzo's Net Worth
$7.51 Million
Who is Richard William Scalzo?
Richard William Scalzo has an estimated net worth of $7.51 Million. This is based on reported shares across multiple companies, which include Dyne Therapeutics, Inc., and Kaleido Biosciences, Inc..
SEC CIK
Richard William Scalzo's CIK is 0001789545
Past Insider Trading and Trends
2024 was Richard William Scalzo's most active year for acquiring shares with 6 total transactions. Richard William Scalzo's most active month to acquire stocks was the month of November. 2024 was Richard William Scalzo's most active year for disposing of shares, totalling 23 transactions. Richard William Scalzo's most active month to dispose stocks was the month of February. 2024 saw Richard William Scalzo paying a total of $517,738.28 for 124,992 shares, this is the most they've acquired in one year. In 2024 Richard William Scalzo cashed out on 263,190 shares for a total of $3,593,125.61, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dyne Therapeutics, Inc. (DYN) Snapshot price: $33.03
SVP, Head Finance & Admin.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.45% | -1.47K |
$31.89 | -$46,814.52 | 99.96K |
Sep 11
| |||
Form 4
| -8.64% | -9.60K |
$22.36 | -$2,589,475.02 | 101.43K |
Sep 6
| |||
Form 4
| -2.42% | -2.75K |
$45.12 | -$124,174.42 | 111.02K |
Aug 19
| |||
Form 4
| -2.50% | -2.92K |
$30.74 | -$89,779.24 | 113.77K |
Jun 10 - Jun 11
| |||
Form 4
| -2.17% | -2.59K |
$28.27 | -$73,161.78 | 116.69K |
May 16
| |||
Form 4
| -2.19% | -2.67K |
$15.87 | -$1,851,170.60 | 119.28K |
Mar 8 - Mar 11
| |||
Form 4
| -1.83% | -2.27K |
$25.85 | -$58,757.05 | 121.95K |
Mar 7
| |||
Form 4
|
—
|
0
|
$14.54 | -$344,174.24 | 124.23K |
Feb 29 - Mar 1
| |||
Form 4
|
—
|
0
|
$12.69 | -$303,030.00 | 124.23K |
Jan 26
| |||
Form 4
|
—
|
0
|
$9.92 | -$231,140.00 | 124.23K |
Jan 3
| |||
Form 4
| -1.88% | -2.38K |
$12.02 | -$28,559.52 | 124.23K |
Scheduled
|
Dec 14
| ||
Form 4
| -1.08% | -1.38K |
$10.72 | -$14,793.60 | 126.6K |
Dec 11
| |||
Form 4
| -1.96% | -2.55K |
$12.01 | -$30,661.53 | 127.98K |
Scheduled
|
Dec 4 - Dec 6
| ||
Form 4
| +219.98% | 89.74K |
—
|
—
| 130.54K |
Nov 15
| |||
Form 4
| -3.07% | -1.29K |
$9.41 | -$12,138.90 | 40.8K |
Sep 18
| |||
Form 4
| -3.21% | -1.40K |
$10.41 | -$14,542.77 | 42.09K |
Sep 12
| |||
Form 4
| -20.76% | -11.39K |
$6.87 | -$611,977.70 | 43.48K |
Jun 13 - Jun 15
| |||
Form 4
| -2.33% | -1.31K |
$13.33 | -$17,475.63 | 54.87K |
Scheduled
|
Mar 14
| ||
Form 4
| +120.37% | 30.69K |
$10.87 | -$3,391.44 | 56.18K |
Scheduled
|
Dec 9 - Dec 12
| ||
Form 4
| -3.19% | -840.00 |
$13.70 | -$11,508.00 | 25.5K |
Scheduled
|
Sep 20
| ||
Form 4
| -1.22% | -326.00 |
$14.05 | -$4,580.30 | 26.34K |
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
| -1.23% | -333.00 |
$4.95 | -$1,648.35 | 26.66K |
Scheduled
|
Jun 14
| ||
Form 4
| -1.13% | -308.00 |
$8.73 | -$2,688.84 | 26.99K |
Scheduled
|
Mar 11
| ||
Form 4
| +157.42% | 16.7K |
—
|
—
| 27.3K |
Dec 10
| |||
Form 4
| -7.49% | -859.00 |
$15.90 | -$13,654.99 | 10.61K |
Scheduled
|
Sep 20 - Sep 21
| ||
Form 4
|
∞
| 11.46K |
—
|
—
| 11.46K |
Sep 16 - Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.0001
Principal Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||